Major histocompatibility complex class II molecules present peptides to CD4+ T cells. New findings indicate that conventional and plasmacytoid dendritic cells handle these molecules differently after activation.
This is a preview of subscription content, log in via an institution to check access.
References
Young, L.J. et al. Nat. Immunol. 9, 1224–1252 (2008).
Bartee, E. et al. J. Virol. 78, 1109–1120 (2004).
Matsuki, Y. et al. EMBO J. 26, 846–854 (2007).
De Gassart, A. et al. Proc. Natl. Acad. Sci. USA 105, 3491–3496 (2008).
Shin, J.S. et al. Nature 444, 115–1118 (2006).
van Niel, G. et al. Immunity 25, 885–894 (2006).
Thibodeau, J. et al. Eur. J. Immunol. 38, 1225–1230 (2008).
Ohmura-Hoshino, M. et al. J. Immunol. 177, 341–354 (2006).
Arndt, S.O. et al. EMBO J. 19, 1241–1251 (2000).
Zwart, W. et al. Immunity 22, 221–223 (2005).
Pierre, P. et al. Nature 388, 787–792 (1997).
Cella, M. et al. Nature 388, 782–787 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van den Hoorn, T., Neefjes, J. Activated pDCs: open to new antigen-presentation possibilities. Nat Immunol 9, 1208–1210 (2008). https://doi.org/10.1038/ni1108-1208
Issue Date:
DOI: https://doi.org/10.1038/ni1108-1208
- Springer Nature America, Inc.